Equity Overview
Price & Market Data
Price: $19.00
Daily Change: $0.00 / 0.00%
Daily Range: $19.00 - $20.00
Market Cap: $660,227,968
Daily Volume: 651
Details
First Tracks Biotherapeutics, Inc. operates as a clinical-stage biotechnology company developing antibody therapeutics that modulate immune pathways implicated in autoimmune and inflammatory diseases. First Tracks Biotherapeutics, Inc. was incorporated in 2025 and is headquartered in San Diego, California. First Tracks Biotherapeutics, Inc. operates as a subsidiary of AnaptysBio, Inc.